comparemela.com

Avast Therapeutics News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Vast Therapeutics Announces Publication of Potential New Treatment for Non-tuberculosis Mycobacteria Infections

/PRNewswire/ Vast Therapeutics announces publication of a manuscript in the journal of Antimicrobial Agents & Chemotherapy describing the utility of its.

Mark schoenfischNathan staskoTherapeutics incAntimicrobial agentsChief scientific officerAvast therapeuticsCystic fibrosis

UK Pharmacy s Dwoskin finishes 2nd in regional competition for biomedical startups

Dwoskin pitched her startup MUDRx, which stands for Methamphetamine Use Disorder Therapeutics. It builds on her research to develop novel therapeutic candidates to treat psychostimulant abuse, specifically for methamphetamine use disorders.

United statesUnited kingdomUniversity of kentuckyLinda dwoskinOleg tsodikovLukeh bradleySylvie garneau tsodikovaTaunya phillipsChicago mayOffice of the viceSubstance use priority research areaUnited kingdom college of pharmacyKentucky network for innovationUniversity professorship in graduate medical educationDepartment of neuroscienceNational academy of inventors

Vast Therapeutics Presents Promising Preclinical Results for Novel Treatment for NTM Disease

/PRNewswire/ Vast Therapeutics announces promising results with a nitric oxide releasing drug candidate under investigation for infections caused by.

John oakleyMark schoenfischTherapeutics incUniversity of south carolinaWorld bronchiectasisMark schoenfisch phdChief scientific officerPatrick flumeMedical universityAvast therapeuticsCystic fibrosisFinancial officer vast therapeutics

Vast Therapeutics Presents Promising Preclinical Results for Novel Treatment for NTM Disease

Vast Therapeutics Presents Promising Preclinical Results for Novel Treatment for NTM Disease
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Mark schoenfischTherapeutics incUniversity of south carolinaWorld bronchiectasisMark schoenfisch phdChief scientific officerPatrick flumeMedical universityAvast therapeuticsCystic fibrosis

Eight startups will compete for $50,000 during Summerfest Tech in MKE

Eight startups will compete for $50,000 during Summerfest Tech in Milwaukee

Third wardUnited statesMarquette universityChuck swobodaCorrinne hessMolson coors beverage coTrex academyMilwaukee world festival incCourt reportersMilwaukee artist resource networkCree incArts hotelMilwaukee young enterprising societyNorthwestern mutualSummerfest techMilwaukee journal

vimarsana © 2020. All Rights Reserved.